These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 32589775)

  • 41. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence.
    Cao YC; Deng QX; Dai SX
    Travel Med Infect Dis; 2020; 35():101647. PubMed ID: 32247927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Physiologically-Based Pharmacokinetic Modeling of Remdesivir and Its Metabolites to Support Dose Selection for the Treatment of Pediatric Patients With COVID-19.
    Lutz JD; Mathias A; German P; Pikora C; Reddy S; Kirby BJ
    Clin Pharmacol Ther; 2021 Apr; 109(4):1116-1124. PubMed ID: 33501997
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhaled remdesivir reduces viral burden in a nonhuman primate model of SARS-CoV-2 infection.
    Vermillion MS; Murakami E; Ma B; Pitts J; Tomkinson A; Rautiola D; Babusis D; Irshad H; Seigel D; Kim C; Zhao X; Niu C; Yang J; Gigliotti A; Kadrichu N; Bilello JP; Ellis S; Bannister R; Subramanian R; Smith B; Mackman RL; Lee WA; Kuehl PJ; Hartke J; Cihlar T; Porter DP
    Sci Transl Med; 2022 Feb; 14(633):eabl8282. PubMed ID: 34968150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Considerations and Challenges in the Remdesivir COVID-19 Pediatric Development Program.
    Chan-Tack K; Sampson M; Earp J; Arya V; Yao L; Alexander J; Hausman E; Belew Y; Birnkrant D; Struble K
    J Clin Pharmacol; 2023 Feb; 63(2):259-265. PubMed ID: 36149807
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Remdesivir, a remedy or a ripple in severe COVID-19?
    Doggrell SA
    Expert Opin Investig Drugs; 2020 Nov; 29(11):1195-1198. PubMed ID: 32896184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.
    Ison MG; Wolfe C; Boucher HW
    JAMA; 2020 Jun; 323(23):2365-2366. PubMed ID: 32407438
    [No Abstract]   [Full Text] [Related]  

  • 47. Efficacy of remdesivir in patients with COVID-19: a protocol for systematic review and meta-analysis of randomised controlled trials.
    Gebrie D; Getnet D; Manyazewal T
    BMJ Open; 2020 Jun; 10(6):e039159. PubMed ID: 32503874
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Delayed Initiation of Remdesivir in a COVID-19-Positive Patient.
    Hillaker E; Belfer JJ; Bondici A; Murad H; Dumkow LE
    Pharmacotherapy; 2020 Jun; 40(6):592-598. PubMed ID: 32281114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Remdesivir and GS-441524 Retain Antiviral Activity against Delta, Omicron, and Other Emergent SARS-CoV-2 Variants.
    Pitts J; Li J; Perry JK; Du Pont V; Riola N; Rodriguez L; Lu X; Kurhade C; Xie X; Camus G; Manhas S; Martin R; Shi PY; Cihlar T; Porter DP; Mo H; Maiorova E; Bilello JP
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0022222. PubMed ID: 35532238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New Perspectives on Antimicrobial Agents: Remdesivir Treatment for COVID-19.
    Aleissa MM; Silverman EA; Paredes Acosta LM; Nutt CT; Richterman A; Marty FM
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33139290
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
    Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
    [No Abstract]   [Full Text] [Related]  

  • 52. Hybrid physiologically-based pharmacokinetic model for remdesivir: Application to SARS-CoV-2.
    Gallo JM
    Clin Transl Sci; 2021 May; 14(3):1082-1091. PubMed ID: 33404204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of remdesivir for patients with Covid-19: a review article.
    Azevedo TCP; Azevedo PCP; Silveira Filho RN; Carvalho ARVS; Cezarotti Filho ML; Barbosa FT; Sousa-Rodrigues CF; Matos-Rocha TJ; Ramos FWDS
    Rev Assoc Med Bras (1992); 2020 Jun; 66(6):838-841. PubMed ID: 32696862
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More.
    Saha A; Sharma AR; Bhattacharya M; Sharma G; Lee SS; Chakraborty C
    Arch Med Res; 2020 Aug; 51(6):585-586. PubMed ID: 32439198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient.
    Alvarez JC; Moine P; Etting I; Annane D; Larabi IA
    Clin Chem Lab Med; 2020 Aug; 58(9):1461-1468. PubMed ID: 32573468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics, safety, and tolerability of inhaled remdesivir in healthy participants.
    Humeniuk R; Juneja K; Chen S; Ellis S; Anoshchenko O; Xiao D; Share A; Johnston M; Davies S; DeZure A; Llewellyn J; Osinusi A; Winter H; Girish S; Palaparthy R; Dresser M
    Clin Transl Sci; 2023 Nov; 16(11):2276-2288. PubMed ID: 37688349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019.
    Barlow A; Landolf KM; Barlow B; Yeung SYA; Heavner JJ; Claassen CW; Heavner MS
    Pharmacotherapy; 2020 May; 40(5):416-437. PubMed ID: 32259313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
    Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Remdesivir (GS-5734) in COVID-19 Therapy: The Fourth Chance.
    Moirangthem DS; Surbala L
    Curr Drug Targets; 2021; 22(12):1346-1356. PubMed ID: 33267759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of Remdesivir in the Management of COVID-19: A Systematic Review on Current Evidences.
    Nasir M; Talha KA; Islam T; Saha SK; Selina F; Parveen RA
    Mymensingh Med J; 2020 Apr; 29(2):481-487. PubMed ID: 32506110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.